Try it
Pharmacology · Chemotherapy: streptozocin in islet cell tumours
Sample itemA man with a metastatic pancreatic neuroendocrine tumour is given a nitrosourea alkylating agent that is taken up selectively by pancreatic beta cells through the GLUT2 transporter. Renal tubular injury is its dose-limiting toxicity. Which drug is this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Streptozocin
Streptozocin is a glucose-linked nitrosourea that enters beta cells through GLUT2 and is used for pancreatic islet cell tumours. It is relatively marrow-sparing, but renal tubular damage limits the dose. It can also cause hyperglycaemia or hypoglycaemia.
Option by option
A. Busulfan
Busulfan is an alkylating agent used in CML and conditioning regimens, with pulmonary fibrosis.
B. Streptozocin (correct)
Correct. Streptozocin enters beta cells via GLUT2 and is nephrotoxic.
C. Dacarbazine
Dacarbazine is a methylating agent used in melanoma and Hodgkin lymphoma, with nausea and marrow suppression.
D. Carmustine
Carmustine is a lipid-soluble nitrosourea used in brain tumours with delayed myelosuppression and pulmonary fibrosis.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?